Skip to content
Mesa Hip Ledger
A cost-and-evidence field guide

Mesa Hip Ledger

Blood-based hip treatment questions have straight answers

What do people ask before choosing a hip treatment? They ask what the treatment is, how much it costs, what change may be realistic, and which warning signs mean a routine appointment isn't soon enough for the sore hip.

How much does a treatment made from my blood cost?

There isn't one set Mesa price because offices may include different visits and follow-up. Ask for the full charge, what's included, how many trips are planned, and which later services could cost more.

Does Medicare pay for platelet-rich plasma (PRP) used in a hip?

An office makes PRP by spinning and concentrating your own blood. Medicare doesn't offer nationwide coverage for PRP used in hip arthritis, so check your share before paying.

Does PRP help a sore hip as much as a sore knee?

Knee results can't predict what will happen in your hip. Hip findings are mixed, so ask how many people walked, slept, or used stairs more easily after treatment.

What can I try at home before paying for a procedure?

Try shorter walks, a firmer chair, and a pause before soreness builds. I'd ask your doctor about gentle strength work and medicine that's safe with your other pills.

Which hip warning signs need prompt medical care right now?

Get medical help when a fever comes with sudden hip heat and swelling, or when a fall leaves you unable to stand. New weakness, numbness, or lost control of your bladder or bowels needs help before an ordinary visit.

Where is the nearest clinic for most Mesa residents?

Most Mesa residents can try 1100 South Dobson Road, Suite 210, in Chandler, after checking the drive from home. North of McDowell, the Scottsdale trip may be shorter, and traffic can change your choice.

Sources

  1. A cross-sectional study contacted 273 of 317 US centres offering direct-to-consumer stem-cell therapy, posing as a 57-year-old man with knee osteoarthritis. The mean advertised price of a unilateral same-day stem-cell knee injection was $5,156 (SD $2,446), and centres claimed a mean clinical efficacy of 82% (SD 9.6%) - a figure with no support in the published evidence. The gap between the quoted number and the trial data is the single most useful thing a patient can be told before a consultation.

    Piuzzi NS, et al. — The Stem-Cell Market for the Treatment of Knee Osteoarthritis: A Patient Perspective.. The journal of knee surgery, 2018. DOI: 10.1055/s-0037-1604443.

  2. Medicare's National Coverage Determination covers autologous platelet-rich plasma ONLY for chronic non-healing diabetic, pressure or venous WOUNDS, and only under Coverage with Evidence Development inside an approved clinical research study. There is no Medicare coverage pathway for PRP as a treatment for osteoarthritis or any other joint indication, which is why these injections are quoted as cash prices.

    Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2012.

  3. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

    US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.

  4. A CDC-led national public health investigation identified culture-confirmed bacterial infections in 20 patients (median age 63) across 8 US states who received umbilical cord blood-derived products marketed as stem cell treatment for pain, osteoarthritis, rheumatoid arthritis and injury. ALL BUT ONE REQUIRED HOSPITALISATION. Of unopened, undistributed product vials sampled, 65% (22 of 34) were contaminated with at least one of 16 bacterial species, mostly enteric; whole-genome sequencing linked an Arizona patient isolate to product administered in Florida.

    Hartnett KP, et al. — Investigation of Bacterial Infections Among Patients Treated With Umbilical Cord Blood-Derived Products Marketed as Stem Cell Therapies.. JAMA network open, 2021. DOI: 10.1001/jamanetworkopen.2021.28615.

  5. A Bayesian network meta-analysis of 11 randomized trials (1353 patients) in hip osteoarthritis found that at 2-4 months and 6 months NO injectable - corticosteroid, hyaluronic acid or platelet-rich plasma - significantly outperformed a saline placebo injection for pain or function. Pooled change from baseline exceeded the minimal clinically important difference in every arm including placebo.

    Gazendam A, et al. — Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials.. British Journal of Sports Medicine, 2021. DOI: 10.1136/bjsports-2020-102179.

  6. In a Level I randomized trial of 111 hip OA patients given three weekly ultrasound-guided injections, the PRP group had the lowest VAS at every follow-up - at 6 months mean VAS 21 (95% CI 15-28) for PRP versus 44 (36-52) for hyaluronic acid (P<.0005) - but the WOMAC advantage was gone by 12 months and adding HA to PRP produced no benefit.

    Dallari D, et al. — Ultrasound-Guided Injection of Platelet-Rich Plasma and Hyaluronic Acid, Separately and in Combination, for Hip Osteoarthritis: A Randomized Controlled Study.. American Journal of Sports Medicine, 2016. DOI: 10.1177/0363546515620383.

  7. FDA states verbatim that regenerative medicine products including stem cells, stromal vascular fraction, umbilical cord blood, Wharton's jelly, amniotic fluid and exosomes have NOT been approved 'for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' The only FDA-approved stem cell products in the United States are blood-forming (hematopoietic progenitor) cells derived from umbilical cord blood, approved only for disorders affecting blood production.

    U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.. FDA, 2026.

Bring your notes and ask about the blood-based treatment

QC Kinetix medical providers are clinic staff who examine you and discuss non-surgical regenerative treatments, including platelet-rich plasma (PRP) prepared in the office by concentrating your blood.

Book a free consultation